G
Globus Medical, Inc. (GMED)
NYQ – Real Time Price. Currency in USD
76.13
-0.55 (-0.72%)
At close: May 12, 2026, 4:00 PM EDT
77.60
+1.47 (1.93%)
After-hours: May 12, 2026, 7:35 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NYQ – Real Time Price. Currency in USD
76.13
-0.55 (-0.72%)
At close: May 12, 2026, 4:00 PM EDT
77.60
+1.47 (1.93%)
After-hours: May 12, 2026, 7:35 PM EDT
No Data
There are no news for this stock.
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 4.26 | 3.40 | 10 | |
| Quick ratio | 2.74 | 2.52 | 10 | |
| Debt to Equity | 0.03 | 1.11 | 9.0 | |
| Debt to Assets | 0.02 | 1.58 | 9.0 | |
| Interest coverage | N/A | 4.33 | 10 | |
| Weighted average score | 9.6 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 1.02B | 1.57B | 2.52B | 2.94B | 2.94B |
| Gross Profit | 741M | 969M | 1.36B | 1.86B | 1.86B |
| Operating Income | 236M | 202M | 232M | 541M | 541M |
| Net Income | 190M | 123M | 103M | 538M | 538M |
| EBITDA | 305M | 347M | 486M | 818M | 818M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | 5.49 | 27.47 | 7.5 |
| Next quarter | 3.77 | -0.85 | 2.5 |
| Current year | 8.99 | 17.3 | 7.5 |
| Next year | 6.36 | 9.09 | 5.5 |
| Weighted average score | 5.8 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 7.46 | 18.18 | 8.47 | -5.36 | 5.3 |
| Y/Y | 25.73 | 430.44 | 52.38 | 4.74 | 8.5 |
| 3y average | 43.54 | 123.57 | 24.9 | 82.93 | 10 |
| 5y average | 31.76 | 88.81 | 23.47 | 51.75 | 10 |
| Weighted average score | 8.5 | ||||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | Medium | 6.0 |
| Intangible assets | Medium | 6.0 |
| Switching costs | Medium | 7.0 |
| Network effect | Medium | 5.0 |
| Economies of scale | Medium | 7.0 |
| Weighted average score | 6.2 | |
Company's cash reserves $526.2M significantly exceed its total debt $119.4M, ensuring strong financial flexibility
Total current assets $2.1B exceed Total current liabilities $498.5M, highlighting excellent liquidity
Debt-to-equity ratio (0.0) is well below the industry average (1.1), showcasing prudent financial management
The company has no interest-bearing debt, showcasing excellent financial strength
The company generates positive free cash flow $202.4M, supporting its financial health